QuidelOrtho logo

QuidelOrthoNASDAQ: QDEL

Profile

Sector:

Healthcare

Country:

United States

IPO:

01 February 1991

Next earnings report:

08 August 2024

Last dividends:

N/A

Next dividends:

N/A
$2.08 B
-71%vs. 3y high
83%vs. sector
-vs. 3y high
-vs. sector
-86%vs. 3y high
31%vs. sector
-81%vs. 3y high
19%vs. sector

Price

after hours | Wed, 03 Jul 2024 20:51:09 GMT
$31.00-$0.36(-1.15%)

Dividend

No data over the past 3 years
$711.00 M$613.54 M
$711.00 M-$1.71 B

Analysts recommendations

Institutional Ownership

QDEL Latest News

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
globenewswire.com24 June 2024 Sentiment: -

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against QuidelOrtho Corporation (NASDAQ: QDEL) on behalf of long-term stockholders following a class action complaint that was filed against QuidelOrtho on April 12, 2024 with a Class Period from February 18, 2022 to April 1, 2024. Our investigation concerns whether the board of directors of QuidelOrtho have breached their fiduciary duties to the company.

The Schall Law Firm Encourages Investors Who Have Suffered Losses In QuidelOrtho Corporation To Make Contact
accesswire.com11 June 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 18, 2022 and April 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 11, 2024.

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
globenewswire.com10 June 2024 Sentiment: -

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
businesswire.com10 June 2024 Sentiment: -

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) common stock between February 18, 2022 and April 1, 2024, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On February 13, 2024, QuidelOrtho released its fou.

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
businesswire.com10 June 2024 Sentiment: -

LOS ANGELES--(BUSINESS WIRE)--DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm.

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders
prnewswire.com10 June 2024 Sentiment: -

NEW YORK , June 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL). Shareholders who purchased shares of QDEL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
globenewswire.com10 June 2024 Sentiment: -

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL) and certain of its officers.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation - QDEL
accesswire.com09 June 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ:QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action – QDEL
globenewswire.com08 June 2024 Sentiment: POSITIVE

NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024, both dates inclusive (the “Class Period”) of the important June 11, 2024 lead plaintiff deadline.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation - QDEL
prnewswire.com07 June 2024 Sentiment: NEGATIVE

NEW YORK , June 7, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") (NASDAQ: QDEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

What type of business is QuidelOrtho?

Quidel Corporation is a manufacturer of medical diagnostic supplies. The company produces a wide range of tests, reagents, devices, and other products for diagnosing viral and bacterial infections, autoimmune diseases, and detecting markers of inflammation. The company also produces bacterial cultures, conducts research in the field of diagnosing oncological diseases, diabetes, and so on. One of the popular solutions from Quidel is the Triage device for rapid detection of prohibited substances in patients' bodies. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

What sector is QuidelOrtho in?

QuidelOrtho is in the Healthcare sector

What industry is QuidelOrtho in?

QuidelOrtho is in the Medical Devices industry

What country is QuidelOrtho from?

QuidelOrtho is headquartered in United States

When did QuidelOrtho go public?

QuidelOrtho initial public offering (IPO) was on 01 February 1991

What is QuidelOrtho website?

https://www.quidelortho.com

Is QuidelOrtho in the S&P 500?

No, QuidelOrtho is not included in the S&P 500 index

Is QuidelOrtho in the NASDAQ 100?

No, QuidelOrtho is not included in the NASDAQ 100 index

Is QuidelOrtho in the Dow Jones?

No, QuidelOrtho is not included in the Dow Jones index

When does QuidelOrtho report earnings?

The next expected earnings date for QuidelOrtho is 08 August 2024